menu
    • menu

    Company profile for Destiny Pharma

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Destiny Pharma plc is a clinical stage, biotechnology company focused on the development of novel medicines that represent a new approach to the treatment of infectious disease. These potential new medicines are being developed to address the need for new drugs for the prevention and treatment of life‑threatening infections caused by antibiotic resistant bacteria, often referred to as superbugs. Infections caused by antibiot...
    Destiny Pharma plc is a clinical stage, biotechnology company focused on the development of novel medicines that represent a new approach to the treatment of infectious disease. These potential new medicines are being developed to address the need for new drugs for the prevention and treatment of life‑threatening infections caused by antibiotic resistant bacteria, often referred to as superbugs. Infections caused by antibiotic resistant strains of bacteria continue to rise at an alarming rate and they pose a major threat to public health in the view of the World Health Organization.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Destiny Pharmaunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Sussex Innovation Centre, Science Park Square, Brighton, BN1 9SB
    Telephone
    Telephone
    +44(0) 1273 704440
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.destinypharma.com/
    Linkedin
    Linkedin
    https://uk.linkedin.com/company/destiny-pharma-ltd
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/destinypharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ENHERTU Launches Adjuvant Phase 3 Trial in HER2+ Endometrial
    ENHERTU Launches Adjuvant Phase 3 Trial in HER2+ Endometrial

    22 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251219192496/en/DESTINY-Endometrial02-Phase-3-Trial-of-ENHERTU-Initiated-as-Adjuvant-Therapy-in-Patients-with-HER2-Expressing-Endometrial-Cancer

    BUSINESSWIRE
    22 Dec 2025
    Share Share
    EMV capital acquires antibiotic assets from destiny pharma
    EMV capital acquires antibiotic assets from destiny pharma

    23 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-23/emv-capital-acquires-antibiotic-assets-from-destiny-pharma

    PHARMAWEB
    23 Sep 2025
    Share Share
    Destiny Goes Private After Failing To Find Partner For Drug
    Destiny Goes Private After Failing To Find Partner For Drug

    15 Jul 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/destiny-goes-private-stay-afloat-after-no-partner-found-anti-infection-drug

    FIERCE BIOTECH
    15 Jul 2024
    Share Share
    Destiny ends COVID collab, Santhera returns lonodelestat
    Destiny ends COVID collab, Santhera returns lonodelestat

    25 Apr 2024

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/destiny-calls-time-sporegen-covid-collab-while-santhera-hands-lonodelestat-back-spexis

    James Waldron FIERCE BIOTECH
    25 Apr 2024
    Share Share
    Destiny Pharma & SporeGen® announce update from research collaboration
    Destiny Pharma & SporeGen® announce update from research collaboration

    02 May 2023

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2023-05-02/destiny-pharma-and-sporegen-announce-update-from-research-collaboration-under-innovate-uk-grant-award-to-develop-a-biotherapeutic-treatment-spor-cov-for-covid-19-and-influenza

    PHARMIWEB
    02 May 2023
    Share Share
    UK biotech hands off mid-stage C. difficile drug in up to $570M deal
    UK biotech hands off mid-stage C. difficile drug in up to $570M deal

    27 Feb 2023

    // Paul Schloesser ENDPTS

    https://endpts.com/uk-biotech-hands-off-mid-stage-c-difficile-drug-in-up-to-570m-deal/

    Paul Schloesser ENDPTS
    27 Feb 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search